PHARMACUITICAL INDUSTRY IN INDIA
Pharmaceuticals Export Promotion Council of India(PEPCI) Report says
#Global Pharma market size in the calendar year 2016 is estimated at $1100 billion as per IMS with a very marginal growth rate of 3%.
#In terms of the global market, India currently holds a modest 1–2% share, but it has been growing at approximately 10% per year
#India’s total exports of Pharmaceuticals (APIs, Generics and Alternative system of medicine) during 2016-17 was $16.84 billion with a negative growth of 0.43%.
#Global generic market is estimated to be of size $ 294 billion. India, a predominant player in Global Generic market has clocked $ 12.7 billion of Exports out of a total $ 294 generic market with a growth of 0.42 % during the year2016-17
CHALLENGES OF HEALTH SECTOR AND PHARMACUITICAL INDUSTRY
1.Accessibility : huge populationof India and their dispersion in difficult and varied geographical regions…
2.Affordability : still lot of people unrmployed or work with meagre salary
3.Quality : better pharma products an essentail requirement..
4.Others : patent issues, corruption and malpractices in govt sector, Environmental concerns….
Overall we can say that pharma industry has a major impact in indian society as its core effects are on
#Health , as a fundamental Right and
#Public Order : in terms of economy, society, environment and ethics……
Therefore this pharma sector become a major cector for regulation……
NATIONAL PHARMACEUITICAL PRICING AUTHORITY (NPPA)
#It is an independent body of experts under the Ministry of Chemicals amd Fertilizers established in the year 1997
#it is not a statutory body
Major functions of NPPA are
- The functions of NPPA include fixation and revision of prices of sheduled drugs (those medicines included in schedule 1 of DPCO which are subject to price control) and formulations
- To implement and enforce the provisions of the Drugs Price Control Order (DPCO), 1995/2013 in accordance with the powers delegated to it
- To undertake and/or sponsor relevant studies in respect of pricing of drugs/formulations.
- To monitor the availability of drugs, identify shortages, if any, and to take remedial steps.
- To collect/maintain data on production, exports and imports, market share of individual companies, profitability of companies etc. for bulk drugs and formulations.
- To deal with all legal matters arising out of the decisions of the Authority.
- To render advice to the Central Government on changes/revisions in the drug policy.
- To render assistance to the Central Government in the parliamentary matters relating to the drug pricing.
- The organisation is entrusted with the task of recovering amounts overcharged by manufacturers for the the controlled drugs from the consumers